Dow Up 1.09% Nasdaq Up 2.12%

More On CADX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Cadence Pharmaceuticals Inc. (CADX)

-NasdaqGS
13.98 0.00(0.00%) Mar 18 - Nasdaq Real Time Price
Prev Close:13.98
Open:13.98
Bid:N/A
Ask:N/A
1y Target Est:11.00
Beta:1.43
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:4.74 - 14.24
Volume:13,202
Avg Vol (3m):3,077,490
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CADX

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback